The A20 protein interacts with the Epstein-Barr virus latent membrane protein 1 (LMP1) and alters the LMP1/TRAF1/TRADD complex

被引:38
作者
Fries, KL
Miller, WE
Raab-Traub, N [1 ]
机构
[1] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA
关键词
D O I
10.1006/viro.1999.9980
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The Epstein-Barr virus (EBV) latent membrane protein 1 (LMP1) interacts with the tumor necrosis factor receptor (TNFR)-associated factor (TRAF) molecules, which are important for LMP1-mediated signaling. Two domains of LMP1 can independently activate NF-kB, carboxyl-terminal activating region 1 (CTAR1) and CTAR2. The activation of NF-kB by CTAR1 occurs through direct interaction of LMP1 with the TRAF molecules, whereas CTAR2 interacts with the TNFR-associated death domain protein (TRADD) to activate NF-kB and the c-Jun N-terminal kinase (JNK). A20, which is induced by LMP1 through NF-kB, can block NF-kB activation from both domains of LMP1 and inhibit JNK activation from CTAR2. A20 also has been shown to associate with TRAF1 and TRAF2. In this study, an interaction between LMP1 and A20 was detected that was increased by TRAF2 overexpression. A20 did not affect the association of TRAF1 with TRAF2 but did displace TRAF1 from the LMP1 complex. The interaction of LMP1 and TRADD was decreased in the presence of A20, and the LMP1-A20 association was decreased by TRADD, suggesting that A20 and TRADD both interact with LMP1 and may compete for binding. These data indicate that A20 alters the interactions between LMP1 and the TRAF molecules and TRADD, affecting the activation of NF-kB, JNK, and perhaps other TRAF-mediated signaling events. (C) 1999 Academic Press.
引用
收藏
页码:159 / 166
页数:8
相关论文
共 39 条
[1]  
Aster JC, 1997, J BIOL CHEM, V272, P11336
[2]   TANK, a co-inducer with TRAF2 of TNF- and CD40L-mediated NF-kappa B activation [J].
Cheng, GH ;
Baltimore, D .
GENES & DEVELOPMENT, 1996, 10 (08) :963-973
[3]   NASOPHARYNGEAL CARCINOMA .10. PRESENCE OF EPSTEIN-BARR GENOMES IN SEPARATED EPITHELIAL-CELLS OF TUMORS IN PATIENTS FROM SINGAPORE, TUNISIA AND KENYA [J].
DESGRANGES, C ;
WOLF, H ;
DETHE, G ;
SHANMUGARATNAM, K ;
CAMMOUN, N ;
ELLOUZ, R ;
KLEIN, G ;
LENNERT, K ;
MUNOZ, N ;
ZURHAUSEN, H .
INTERNATIONAL JOURNAL OF CANCER, 1975, 16 (01) :7-15
[4]  
Devergne O, 1996, MOL CELL BIOL, V16, P7098
[5]   Role of the TRAF binding site and NF-κB activation in Epstein-Barr virus latent membrane protein 1-induced cell gene expression [J].
Devergne, O ;
McFarland, EC ;
Mosialos, G ;
Izumi, KM ;
Ware, CF ;
Kieff, E .
JOURNAL OF VIROLOGY, 1998, 72 (10) :7900-7908
[6]   Epstein-Barr virus-encoded latent membrane protein 1 activates the JNK pathway through its extreme C terminus via a mechanism involving TRADD and TRAF2 [J].
Eliopoulos, AG ;
Blake, SMS ;
Floettmann, JE ;
Rowe, M ;
Young, LS .
JOURNAL OF VIROLOGY, 1999, 73 (02) :1023-1035
[7]   Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappa B pathway involving TNF receptor-associated factors [J].
Eliopoulos, AG ;
Stack, M ;
Dawson, CW ;
Kaye, KM ;
Hodgkin, L ;
Sihota, S ;
Rowe, M ;
Young, LS .
ONCOGENE, 1997, 14 (24) :2899-2916
[8]   Identification of a novel protein encoded by the BamHI A region of the Epstein-Barr virus [J].
Fries, KL ;
Sculley, TB ;
WebsterCyriaque, J ;
Rajadurai, P ;
Sadler, RH ;
RaabTraub, N .
JOURNAL OF VIROLOGY, 1997, 71 (04) :2765-2771
[9]   Epstein-Barr virus latent membrane protein 1 blocks p53-mediated apoptosis through the induction of the A20 gene [J].
Fries, KL ;
Miller, WE ;
RaabTraub, N .
JOURNAL OF VIROLOGY, 1996, 70 (12) :8653-8659
[10]   CD30 contains two binding sites with different specificities for members of the tumor necrosis factor receptor-associated factor family of signal transducing proteins [J].
Gedrich, RW ;
Gilfillan, MC ;
Duckett, CS ;
VanDongen, JL ;
Thompson, CB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (22) :12852-12858